Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Paliperidone palmitate effective in phase III schizophrenia study

May 20, 2008

Ki-20227 reduces the severity of experimental autoimmune encephalomyelitis

May 20, 2008

Zinc finger protein transcription factors show potential in treating pain

May 20, 2008

Novel analgesic agents described in recent patents

May 19, 2008

Pozen transfers IND and NDA for migraine drug Treximet to GSK

May 19, 2008

FDA puts Geron's IND application for GRNOPC1 on clinical hold

May 19, 2008

Wyeth's Pristiq available in U.S. pharmacies for major depressive disorder

May 16, 2008

Orexo submits NDA to the FDA for Sublinox (OX-22) for short-term insomnia

May 16, 2008

Pfizers's ziprasidone under study in children and adolescents with bipolar I disorder

May 16, 2008

Valeant reports positive results from phase III RESTORE 2 trial of retigabine in epilepsy

May 16, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...